Revenue and EBITDA Growth
Revenue for the quarter was $382.7 million, a 3% increase over last year. Adjusted EBITDAre came in at $73.6 million, up 7% year-over-year.
Significant Increase in FFO
FFO increased 172% year-over-year to $18.6 million or $0.08 per share.
SHOP Segment Performance
An 18.5% year-over-year increase in same-property SHOP NOI, with occupancy increasing 160 basis points to 80.6% and average monthly rate increasing 5.4%.
Leasing Activity in Medical Office and Life Science Portfolio
Completed over 106,000 square feet of new and renewal leasing activity with weighted average rents 11.5% higher than prior rents.
Successful Asset Dispositions
Sold 2 unencumbered properties for $16.4 million and 3 more properties in July for $8.8 million.
Increased Liquidity
Ended the quarter with approximately $292 million of liquidity, including $142 million of unrestricted cash and $150 million available under the new credit facility.